BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16099693)

  • 1. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Manning BJ; Hynes N; Courtney DF; Sultan S
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions.
    Mittal S; Watson HG
    Br J Haematol; 2006 May; 133(4):355-63. PubMed ID: 16643441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors.
    O'Connell N; Mc Mahon C; Smith J; Khair K; Hann I; Liesner R; Smith OP
    Br J Haematol; 2002 Mar; 116(3):632-5. PubMed ID: 11849223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Life-threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use].
    Courtois L; Becher P; Miot S; Maisonnette-Escot Y; Sautière JL; Berthier F; Samain E; Maillet R; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):78-82. PubMed ID: 17293258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate haemostasis with recombinant factor VIIa for haemorrhage following Hickman line insertion in acute myeloid leukaemia.
    Osborne W; Bhandari S; Tait RC; Franklin IM
    Clin Lab Haematol; 2004 Jun; 26(3):229-31. PubMed ID: 15163323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor VIIa and the surgical patient.
    Scarpelini S; Rizoli S
    Curr Opin Crit Care; 2006 Aug; 12(4):351-6. PubMed ID: 16810047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings of the 6th Novo Nordisk Symposium on Treatment of Bleeding and Thrombotic Disorders. Copenhagen, Denmark, May 3-4, 2001.
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):1-50. PubMed ID: 11840984
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study.
    Hay CR; Negrier C; Ludlam CA
    Thromb Haemost; 1997 Dec; 78(6):1463-7. PubMed ID: 9423795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical bleeding in vascular surgery: expanding the indication of recombinant activated factor VII.
    Tawfick WA; Tawfik S; Hynes N; Mahendran B; Sultan S
    Vascular; 2006; 14(1):32-7. PubMed ID: 16849021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of recombinant activated factor VII in massive obstetric haemorrhage.
    Haynes J; Laffan M; Plaat F
    Int J Obstet Anesth; 2007 Jan; 16(1):40-9. PubMed ID: 17126006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of recombinant factor VIIa for bleeding in paediatric practice.
    Millar CG; Stringer MD; Sugarman I; Richards M
    Haemophilia; 2005 Mar; 11(2):171-4. PubMed ID: 15810920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant factor VIIa for adjunctive hemorrhage control in trauma and surgical patients.
    Benharash P; Bongard F; Putnam B
    Am Surg; 2005 Sep; 71(9):776-80. PubMed ID: 16468517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.
    Hamaekers AE; van Mook WN; Offermans JP; Marcus MA
    Am J Crit Care; 2006 Jul; 15(4):399-401. PubMed ID: 16823017
    [No Abstract]   [Full Text] [Related]  

  • 14. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
    Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P
    Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant factor VIIa in massive postpartum haemorrhage.
    Karalapillai D; Popham P
    Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of factor XI inhibitor using recombinant activated factor VIIa.
    Bern MM; Sahud M; Zhukov O; Qu K; Mitchell W
    Haemophilia; 2005 Jan; 11(1):20-5. PubMed ID: 15660984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidotes to haemorrhage: recombinant factor VIIa.
    Kessler CM
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):183-97. PubMed ID: 15171966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant activated factor VII: a solution to refractory haemorrhage in vascular surgery?
    Warren OJ; Alcock EM; Choong AM; Leff DR; Van Herzeele I; Darzi AW; Athanasiou T; Cheshire NJ
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):145-52. PubMed ID: 17964194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
    Hardy JF
    Can J Anaesth; 2002 Dec; 49(10):S4-6. PubMed ID: 12545999
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of activated recombinant FVII in the control of haemorrhage following trauma].
    Perrier V; Morel N; Bernard JC; Julliac B; Dewitte A; Pouquet O; Sztark F; Dabadie P
    Ann Fr Anesth Reanim; 2006 Sep; 25(9):990-3. PubMed ID: 16926088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.